Drugs / BMS-707035
last change Feb 2007 re-read 3 minutes ago

BMS-707035

Small molecule

Developed for
HIV infectious disease
Investigated by
Bristol-Myers Squibb

Trials 1

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00397566 Feb 2007 HIV infectious disease Bristol-Myers Squibb Withdrawn No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as BMS-707035 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00397566 ↗
Action Inhibit “HIV Integrase Inhibitor” NCT00397566 ↗
Modality Small molecule — CHEMBL486226 ↗